Published in Biochem Biophys Res Commun on January 18, 2007
Systems pharmacology of arrhythmias. Sci Signal (2010) 1.72
KCNE1 D85N polymorphism--a sex-specific modifier in type 1 long QT syndrome? BMC Med Genet (2011) 0.89
Oxidative modulation of voltage-gated potassium channels. Antioxid Redox Signal (2013) 0.89
KCNE1 and KCNE3: The yin and yang of voltage-gated K(+) channel regulation. Gene (2015) 0.89
Next-generation sequencing of 100 candidate genes in young victims of suspected sudden cardiac death with structural abnormalities of the heart. Int J Legal Med (2015) 0.86
Modification by KCNE1 variants of the hERG potassium channel response to premature stimulation and to pharmacological inhibition. Physiol Rep (2013) 0.84
18β-Glycyrrhetinic acid preferentially blocks late Na current generated by ΔKPQ Nav1.5 channels. Acta Pharmacol Sin (2012) 0.78
LQT5 masquerading as LQT2: a dominant negative effect of KCNE1-D85N rare polymorphism on KCNH2 current. Europace (2011) 0.78
Myriad roles of voltage-activated potassium channel subunit Kvβ1.1 in the heart. Am J Physiol Heart Circ Physiol (2017) 0.75
Cardiovascular Action of Insulin in Health and Disease: Endothelial L-Arginine Transport and Cardiac Voltage-Dependent Potassium Channels. Front Physiol (2016) 0.75
Single-copy insertion of transgenes in Caenorhabditis elegans. Nat Genet (2008) 7.58
The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio (2013) 2.64
The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat (2009) 2.54
Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol (2008) 2.42
Incidence and etiology of sports-related sudden cardiac death in Denmark--implications for preparticipation screening. Heart Rhythm (2010) 2.34
Mutations in the HERG K+-ion channel: a novel link between long QT syndrome and sudden infant death syndrome. Am J Cardiol (2005) 2.20
The KCNQ1 potassium channel: from gene to physiological function. Physiology (Bethesda) (2005) 2.11
Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations. Circ Res (2006) 2.05
The KCNQ1 potassium channel is down-regulated by ubiquitylating enzymes of the Nedd4/Nedd4-like family. Cardiovasc Res (2007) 2.03
A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome. Cardiovasc Res (2008) 2.01
[Prenatal diagnosis of Down syndrome in Denmark 1980-1998 and future progress perspectives]. Ugeskr Laeger (2002) 1.97
Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. Am J Hum Genet (2012) 1.89
Nationwide study of sudden cardiac death in persons aged 1-35 years. Eur Heart J (2010) 1.87
New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants. Eur J Hum Genet (2013) 1.80
Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J (2008) 1.76
Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography. Eur J Echocardiogr (2011) 1.72
Contribution of Kv7 channels to basal coronary flow and active response to ischemia. Hypertension (2013) 1.70
KCNE4 is an inhibitory subunit to the KCNQ1 channel. J Physiol (2002) 1.70
Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women. Eur J Heart Fail (2010) 1.69
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest (2008) 1.69
The prevalence of mutations in KCNQ1, KCNH2, and SCN5A in an unselected national cohort of young sudden unexplained death cases. J Cardiovasc Electrophysiol (2012) 1.65
Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J (2006) 1.63
Screening of KCNN3 in patients with early-onset lone atrial fibrillation. Europace (2011) 1.63
Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations. Cardiovasc Res (2003) 1.61
Phosphorylation of connexin43 on serine 306 regulates electrical coupling. Heart Rhythm (2009) 1.60
QT dynamics in risk stratification after myocardial infarction. Heart Rhythm (2005) 1.59
Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphology. Drug Saf (2009) 1.58
Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J (2005) 1.58
High prevalence of genetic variants previously associated with LQT syndrome in new exome data. Eur J Hum Genet (2012) 1.58
Sharing data between LSDBs and central repositories. Hum Mutat (2009) 1.57
Identification of a Kir3.4 mutation in congenital long QT syndrome. Am J Hum Genet (2010) 1.57
Low disease prevalence and inappropriate implantable cardioverter defibrillator shock rate in Brugada syndrome: a nationwide study. Europace (2012) 1.53
Rare variants in GJA5 are associated with early-onset lone atrial fibrillation. Can J Cardiol (2012) 1.53
Role of small-conductance calcium-activated potassium channels in atrial electrophysiology and fibrillation in the dog. Circulation (2013) 1.51
Pharmacological activation of IKr impairs conduction in guinea pig hearts. J Cardiovasc Electrophysiol (2010) 1.50
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. Rev Esp Cardiol (Engl Ed) (2015) 1.49
Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing. Circulation (2012) 1.49
Loss-of-function polymorphic variants of the human angiotensin II type 1 receptor. Mol Pharmacol (2004) 1.48
T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome. Heart Rhythm (2004) 1.46
Flecainide provocation reveals concealed brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A. Circ J (2014) 1.45
The role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygote. Circ Cardiovasc Genet (2013) 1.44
The genetic basis of Brugada syndrome: a mutation update. Hum Mutat (2009) 1.44
Sodium current and potassium transient outward current genes in Brugada syndrome: screening and bioinformatics. Can J Cardiol (2012) 1.43
Mechanism of action of a novel human ether-a-go-go-related gene channel activator. Mol Pharmacol (2005) 1.43
Point-of-care time-resolved immunofluorometric assay for human pregnancy-associated plasma protein A: use in first-trimester screening for Down syndrome. Clin Chem (2002) 1.40
Prior myocardial infarction in the young: predisposes to a high relative risk but low absolute risk of a sudden cardiac death. Europace (2012) 1.40
The prevalence and relevance of the Brugada-type electrocardiogram in the Danish general population: data from the Copenhagen City Heart Study. Europace (2010) 1.40
The phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R). Heart Rhythm (2013) 1.40
Assessing QT interval prolongation and its associated risks with antipsychotics. CNS Drugs (2011) 1.39
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Rev Esp Cardiol (Engl Ed) (2016) 1.39
[Sudden unexpected cardiac death in an 18-year-old female with familial hypercholesterolaemia]. Ugeskr Laeger (2013) 1.39
Requirement of subunit co-assembly and ankyrin-G for M-channel localization at the axon initial segment. J Cell Sci (2007) 1.39
KCNE5 induces time- and voltage-dependent modulation of the KCNQ1 current. Biophys J (2002) 1.39
KCNQ1 mutation Q147R is associated with atrial fibrillation and prolonged QT interval. Heart Rhythm (2007) 1.39
Mutations in sodium channel β-subunit SCN3B are associated with early-onset lone atrial fibrillation. Cardiovasc Res (2010) 1.38
Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Mol Pharmacol (2005) 1.37
Inhibition of small-conductance Ca2+-activated K+ channels terminates and protects against atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 1.36
BK channel modulators: a comprehensive overview. Curr Med Chem (2008) 1.35
Dissecting spatio-temporal protein networks driving human heart development and related disorders. Mol Syst Biol (2010) 1.35
Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation. Heart Rhythm (2008) 1.27
Pierre Robin sequence may be caused by dysregulation of SOX9 and KCNJ2. J Med Genet (2007) 1.27
Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives. Hum Mutat (2009) 1.26
Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynecol (2005) 1.26
One third of Danish hypertrophic cardiomyopathy patients with MYH7 mutations have mutations [corrected] in MYH7 rod region. Eur J Hum Genet (2005) 1.25
In vivo phosphoproteomics analysis reveals the cardiac targets of β-adrenergic receptor signaling. Sci Signal (2013) 1.22
The prognostic value of the Tpeak-Tend interval in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Electrocardiol (2009) 1.21
SCN1Bb R214Q found in 3 patients: 1 with Brugada syndrome and 2 with lone atrial fibrillation. Heart Rhythm (2011) 1.21